FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fresenius Kabi sodium chloride injection recalled for sterility concerns

OTHERNationwide distributionDrugs

What this means

Fresenius Kabi is recalling specific batches of 0.9% Sodium Chloride Injection (saline solution) used in medical settings because the manufacturer cannot guarantee the product is sterile. The affected batches were distributed nationwide. No injuries have been reported so far.

  • If you use or administer this product, check the batch number and expiration date against the recall (Batch# 23DU10004, Exp 04/30/2026 or Batch# 23HU10006, Exp 06/30/2026)
  • Do not use recalled batches; return them to your pharmacy or healthcare facility
  • Contact your doctor or pharmacist if you have questions about your care
The agency's original wording
Hazard

Lack of Assurance of Sterility

Intended for
All ages (0 months and older)
Illnesses reported
None reported
Sold states
US Nationwide , Alaska, and Puerto Rico.
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Products
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of Use NDC: 65219-432-20, Unit of Sale NDC Number: 65219-432-85.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0432-2026

More Fresenius Kabi recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime